Roy P, Banik D, Chowdhury F, Bakar Siddique MA. Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials. World J Oncol. 2026;17(5):599-613. doi:10.14740/wjon2842